By Malcolm Stacey | Thursday 23 December 2021
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello, Share Groovers. It’s taken a fair time but Avacta Group (AVCT) has been awarded a coveted CE mark for its Covid antigen lateral flow test. That means that its self-test kits can be sold in the EU and Blighty. The news sent the shares up by 25% at one point. There could be more to come.